The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.41%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 42.00
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

23 Dec 2013 07:00

RNS Number : 1772W
Avacta Group PLC
23 December 2013
 



 

 

 

Avacta Group plc

("Avacta" or the "Group")

 

Craig Slater joins the Board of Avacta Group plc as Chief Operating Officer

 

Avacta Group plc, the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, is pleased to announce that Craig Slater has joined the Board as Chief Operating Officer with immediate effect.

 

Mr Slater has more than 25 years experience of commercial, operational and group management roles in specialist engineering, construction, software and marketing groups. More specifically this experience includes the supply of specialist equipment to Life Science clients, B2B service provision and the implementation of growth plans in SME businesses. Mr Slater has been working with Avacta since June 2012, primarily in a commercial and operational capacity within Avacta Analytical and latterly within Avacta Animal Health.

 

Commenting on the appointment, Alastair Smith, Chief Executive of Avacta said: "The Board is delighted that Craig is joining the Group as Chief Operating Officer. We have already benefited greatly from his experience since he joined us in 2012 and his operational and strategic input will be invaluable in the future."

 

Mr Slater, aged 50, is a director/partner or has been a director/partner of the following companies/partnerships during the previous five years:

 

Current Directorships

Veracito Limited

QPC Holdings Limited

Adapt Formwork Holdings Limited

Adapt Formwork Limited

Gateway 3D Limited

Sitedesk Limited

 

Previous Directorships (in last 5 years)

Eleco Public Limited Company

Bell & Webster Concrete Limited

Milbury Systems Limited

Eleco (Pp) Limited

Eleco (Dcs) Limited

Eleco (Spp) Limited

Eleco (Gns) Limited

Eleco (Sd) Limited

CORGI Group Limited

Corgi Gas Registration Limited

Corgi Services Limited

Altitude Group Plc

Adproducts.com Limited

Advertising Gifts Limited

Advertising Gifts.net Limited

Boxcam Limited

Brand Logistics Limited

Business Gifts Limited

Corporate Gifts Limited

Corporate Solutions (UK) Limited

Distinctive Ideas Limited

Dowlis Corporate Solutions (UK) Limited

Promoserve Business Systems Limited

Promotional Gifts Limited

Promotional Items Limited

Promotional Merchandise Limited

Promotional Store Limited

Ross Promotional Products Limited

Silent Kite Limited

The Advertising Products Group Limited

The Bentley Collection Limited

Touchpaper Communications Limited

Trade Only Limited

 

Mr Slater does not hold any ordinary shares, or options over ordinary shares, in the Company.

 

Save for the information disclosed above there is no other information to be disclosed on Mr Slater under Schedule 2(g) of the AIM Rules.

 

- Ends -

 

Enquiries:

 

Avacta Group plc

www.avacta.com

Alastair Smith, Chief Executive Officer

Tel: +44 (0) 844 414 0452

Tim Sykes, Chief Financial Officer

 

 

 

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

 

James Black (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780 or avacta@walbrookpr.com

Mike Wort

Mob: +44 (0)7900 608 002

Lianne Cawthorne

Mob: +44 (0)7584 391 303

 

 

About Avacta Group plc - www.avacta.com

 

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:

 

Avacta Analytical

www.avactaanalytical.com

 

High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.

Avacta Animal Health

www.avactaanimalhealth.com

 

Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod.

Avacta Life Sciences

www.avactalifesciences.com

 

Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

 

Avacta joined AIM in August 2006 and is based in Wetherby, England.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFEWFFFFDSELE
Date   Source Headline
11th Aug 20217:00 amRNSFirst Patient Dosed in AVA6000 Phase 1 Trial
4th Aug 20217:00 amRNSUpdate on AffiDX Lateral Flow Test
14th Jul 20217:00 amRNSDiagnostics achieves ISO 13485 Certification
12th Jul 20214:41 pmRNSSecond Price Monitoring Extn
12th Jul 20214:35 pmRNSPrice Monitoring Extension
29th Jun 20217:00 amRNSAffiDX Lateral Flow Test Detects Delta Variant
28th Jun 202112:13 pmRNSResult of AGM
21st Jun 20212:05 pmRNSSecond Price Monitoring Extn
21st Jun 20212:00 pmRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSAffiDX Lateral Flow Test Distribution Agreement
15th Jun 20218:00 amRNSIssue of Equity and Total Voting Rights
11th Jun 20212:05 pmRNSSecond Price Monitoring Extn
11th Jun 20212:00 pmRNSPrice Monitoring Extension
11th Jun 202111:07 amRNSRegistration of AffiDX Lateral Flow Test in EU
9th Jun 20219:08 amRNSHolding(s) in Company
7th Jun 20217:00 amRNSMHRA Confirms Registration of Lateral Flow Test
1st Jun 20217:00 amRNSUpdate on Lateral Flow Test Regulatory Submissions
28th May 20217:00 amRNSResponse to speculation
25th May 202110:00 amRNSPosting of Annual Report and Notice of AGM
10th May 202110:36 amRNSAffiDX SARS-CoV-2 Antigen Lateral Flow Test Update
6th May 20217:00 amRNSChange of Nominated Adviser
30th Apr 202112:37 pmRNSIssue of Equity
28th Apr 20215:18 pmRNSIssue of Equity
28th Apr 20214:41 pmRNSSecond Price Monitoring Extn
28th Apr 20214:36 pmRNSPrice Monitoring Extension
22nd Apr 20217:00 amRNSFinal Results
20th Apr 202111:05 amRNSSecond Price Monitoring Extn
20th Apr 202111:00 amRNSPrice Monitoring Extension
20th Apr 20217:00 amRNSClinical validation of AffiDX Lateral Flow Test
15th Apr 20214:36 pmRNSPrice Monitoring Extension
13th Apr 20217:00 amRNSNotice of Results and Investor Presentation
12th Apr 20211:30 pmRNSIssue of Equity
6th Apr 20217:00 amRNSDistribution Agreement with ABCAM plc
25th Mar 20213:01 pmRNSDirectorate Change
16th Mar 20215:08 pmRNSIssue of Equity
15th Mar 20215:22 pmRNSIssue of Equity
9th Mar 20217:00 amRNSDiagnostic Licensing Deal with Biokit
8th Mar 20217:00 amRNSRapid Antigen Test Detects SARS-CoV-2 Variants
3rd Mar 20215:14 pmRNSElectronic Communications with Shareholders
24th Feb 20217:00 amRNSBusiness Update
22nd Feb 20217:00 amRNSRe: Press Speculation
18th Feb 20217:00 amRNSPhase I CTA for AVA6000 Approved by MHRA
16th Feb 20219:05 amRNSSecond Price Monitoring Extn
16th Feb 20219:00 amRNSPrice Monitoring Extension
16th Feb 20217:00 amRNSResults of Initial Evaluation of SARS-CoV-2 LFT
8th Feb 20217:00 amRNSCommercial Partnership with Mologic
2nd Feb 20218:30 amRNSIssue of Equity
1st Feb 20217:00 amRNSAffyXell $7.3 Million Series A Financing
29th Jan 202111:00 amRNSIssue of Equity
28th Jan 20217:00 amRNSCollaboration Agreement with Bruker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.